Brightgene Bio-medical Technology Co (SHSE:688166) Selling and Marketing Expense : ¥61 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Brightgene Bio-medical Technology Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Brightgene Bio-medical Technology Co's Selling and Marketing Expense for the three months ended in Mar. 2025 was ¥17 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥61 Mil.

Brightgene Bio-medical Technology Co Selling and Marketing Expense Historical Data

The historical data trend for Brightgene Bio-medical Technology Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brightgene Bio-medical Technology Co Selling and Marketing Expense Chart

Brightgene Bio-medical Technology Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Selling and Marketing Expense

Get a 7-Day Free Trial

12.93

36.60

62.27

54.91

58.39

Brightgene Bio-medical Technology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Selling and Marketing Expense	Get a 7-Day Free Trial															14.81	19.82	21.61	2.15	17.43

Brightgene Bio-medical Technology Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥61 Mil.

Brightgene Bio-medical Technology Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Brightgene Bio-medical Technology Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Brightgene Bio-medical Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brightgene Bio-medical Technology Co Ltd (SHSE:688166) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xinghu Street, Industrial Park, Building C25-C28, Bio-Nano Park, No. 218, Suzhou, CHN, 215123

Website

http://www.bright-gene.com

Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of new drugs and high-end generic drugs. The company develops macrolides, peptides, polysaccharides, heterocycles, azoles, azines, phenyl ethers, tetracyclines, and production of non-pharmaceutical macrolides, peptides, polysaccharides, heterocycles, azoles, azines, benzene Ethers, tetracyclines.

Brightgene Bio-medical Technology Co Headlines

No Headlines